These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8963665

  • 1. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
    You ZB, Herrera-Marschitz M, Nylander I, Goiny M, Kehr J, Ungerstedt U, Terenius L.
    Brain Res; 1996 Feb 26; 710(1-2):241-8. PubMed ID: 8963665
    [Abstract] [Full Text] [Related]

  • 2. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou HZ, Kehr J, Godukhin O, Hökfelt T, Terenius L, Ungerstedt U.
    Neuroscience; 1996 Oct 26; 74(3):793-804. PubMed ID: 8884775
    [Abstract] [Full Text] [Related]

  • 3. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides.
    You ZB, Herrera-Marschitz M, Terenius L.
    J Pharmacol Exp Ther; 1999 Sep 26; 290(3):1307-15. PubMed ID: 10454508
    [Abstract] [Full Text] [Related]

  • 4. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB, Herrera-Marschitz M, Nylander I, Goiny M, O'Connor WT, Ungerstedt U, Terenius L.
    Neuroscience; 1994 Nov 26; 63(2):427-34. PubMed ID: 7891856
    [Abstract] [Full Text] [Related]

  • 5. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
    You ZB, Nylander I, Herrera-Marschitz M, O'Connor WT, Goiny M, Terenius L.
    Neuroscience; 1994 Nov 26; 63(2):415-25. PubMed ID: 7891855
    [Abstract] [Full Text] [Related]

  • 6. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.
    Bustamante D, You ZB, Castel MN, Johansson S, Goiny M, Terenius L, Hökfelt T, Herrera-Marschitz M.
    J Neurochem; 2002 Nov 26; 83(3):645-54. PubMed ID: 12390526
    [Abstract] [Full Text] [Related]

  • 7. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.
    You ZB, Saria A, Fischer-Colbrie R, Terenius L, Goiny M, Herrera-Marschitz M.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec 26; 354(6):717-24. PubMed ID: 8971731
    [Abstract] [Full Text] [Related]

  • 8. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M, O'Connor WT, Ungerstedt U, Bianchi C, Fuxe K.
    Neuroscience; 1996 May 26; 72(1):89-97. PubMed ID: 8730708
    [Abstract] [Full Text] [Related]

  • 9. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis.
    Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, Godukhin OV, Chen Y, Espinoza S, Pettersson E, Loidl CF, Lubec G, Andersson K, Nylander I, Terenius L, Ungerstedt U.
    J Neurochem; 1996 Apr 26; 66(4):1726-35. PubMed ID: 8627331
    [Abstract] [Full Text] [Related]

  • 10. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P, Mura MA, Esposito G, Serra P, Migheli R, De Natale G, Desole MS, Miele M, Miele E.
    Brain Res; 1998 Jun 22; 797(1):94-102. PubMed ID: 9630540
    [Abstract] [Full Text] [Related]

  • 11. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis.
    You ZB, Pettersson E, Herrera-Marschitz M, Hökfelt T, Terenius L, Nylander I, Goiny M, Hughes J, O'Connor WT, Ungerstedt U.
    Neuroreport; 1994 Nov 21; 5(17):2301-4. PubMed ID: 7881050
    [Abstract] [Full Text] [Related]

  • 12. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M, Besson MJ.
    Neuroscience; 1999 Nov 21; 92(3):945-66. PubMed ID: 10426535
    [Abstract] [Full Text] [Related]

  • 13. Lesions of nucleus accumbens affect morphine-induced release of ascorbic acid and GABA but not of glutamate in rats.
    Sun JY, Yang JY, Wang F, Wang JY, Song W, Su GY, Dong YX, Wu CF.
    Addict Biol; 2011 Oct 21; 16(4):540-50. PubMed ID: 20731632
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
    Abarca J, Bustos G.
    Neurochem Int; 1999 Jul 21; 35(1):19-33. PubMed ID: 10403427
    [Abstract] [Full Text] [Related]

  • 15. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P, Sarre S, Ebinger G, Michotte Y.
    Eur J Pharmacol; 2000 Jul 07; 399(2-3):151-60. PubMed ID: 10884514
    [Abstract] [Full Text] [Related]

  • 16. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 17. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
    Mark KA, Soghomonian JJ, Yamamoto BK.
    J Neurosci; 2004 Dec 15; 24(50):11449-56. PubMed ID: 15601951
    [Abstract] [Full Text] [Related]

  • 18. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ, Taylor DA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May 15; 355(5):582-8. PubMed ID: 9151296
    [Abstract] [Full Text] [Related]

  • 19. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB, Godukhin O, Goiny M, Nylander I, Ungerstedt U, Terenius L, Hökfelt T, Herrera-Marschitz M.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May 15; 355(5):576-81. PubMed ID: 9151295
    [Abstract] [Full Text] [Related]

  • 20. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine.
    Watson CJ, Lydic R, Baghdoyan HA.
    Neuroscience; 2007 Jan 05; 144(1):375-86. PubMed ID: 17055662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.